Biotricity Inc.

Biotricity Inc.

OOTC:BTCY
0.05
USD
-0.01
(-13.17%)
-0.10EPS
2.51MMarket Cap

Total Valuation

USD

As of June 30, 2026, Biotricity Inc. carries a market capitalization of 2.51M, placing it among publicly traded companies globally. Its enterprise value stands at 33.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.51M
Enterprise Value33.12M

Important Dates

Biotricity Inc.'s next confirmed earnings release is scheduled for November 16, 2026.

Earnings Date11/16/2026

Share Statistics

As of June 30, 2026, Biotricity Inc. has 20.24M shares outstanding.

Shares Outstanding20.24M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.20, and the price-to-book ratio stands at -0.07.

PS Ratio0.20
PB Ratio-0.07
P/TBV Ratio-0.07
P/FCF Ratio20.37
P/OCF Ratio20.37

Enterprise Valuation

As of June 30, 2026, Biotricity Inc. trades at an EV/EBITDA multiple of 21.05 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 21.13 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 33.12M versus a market cap of 2.51M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.02
EV / EBITDA21.05
EV / EBIT21.13

Financial Position

As of June 30, 2026, Biotricity Inc. maintains a current ratio of 0.15, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -79.93, indicating conservative leverage, while an interest coverage ratio of 0.38 demonstrates limited ability to service its debt obligations.

Current Ratio0.15
Quick Ratio0.11
Debt / Equity-79.93
Debt / EBITDA17.12
Interest Coverage0.38

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -44.63, reflecting losses generated across the asset base. The company generates approximately 356,547.87 in revenue per employee across its workforce of 46.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.89 indicates how many times Biotricity Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-44.63
Revenue Per Employee356,547.87
Employee Count46.00
Inventory Turnover1.89

Stock Price Statistics

USD

As of the close on November 16, 2026, Biotricity Inc.'s stock has declined approximately 90.89% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.16.

52-Week Price Change-90.89%
50-Day Moving Average0.06
200-Day Moving Average0.16

Income Statement

USD

Over the twelve months ended June 30, 2026, Biotricity Inc. generated 16.40M in revenue and converted that into -2.69M in net income, yielding earnings per share of -0.10. EBITDA reached 1.57M, while operating income came in at 1.57M.

Revenue16.40M
Gross Profit13.36M
Operating Income1.57M
Pretax Income-2.69M
Net Income-2.69M
EBITDA1.57M
EBIT1.57M
Earnings Per Share (EPS)-0.10

Balance Sheet

USD

As of June 30, 2026, Biotricity Inc. holds 466,503.00 in cash and equivalents against 26.93M in total debt, resulting in a net debt position of 26.21M. Total book value stands at -37.84M, with working capital of -31.75M providing operational flexibility.

Cash & Cash Equivalents466,503.00
Total Debt26.93M
Net Debt26.21M
Equity (Book Value)-37.84M
Book Value Per Share-1.87
Working Capital-31.75M

Cash Flow

USD

Biotricity Inc. produced 161,661.00 in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled 161,661.00 - equivalent to 0.01 per share.

Operating Cash Flow161,661.00
Free Cash Flow161,661.00
FCF Per Share0.01

Margins

Over the twelve months ended June 30, 2026, Biotricity Inc. posted a gross margin of 81.47, reflecting its pricing power and cost economics. The operating margin of 9.56 and net profit margin of -16.41 provide insight into operational efficiency.

Gross Margin81.47
Operating Margin9.56
Pretax Margin-16.41
Profit Margin-16.41
EBITDA Margin9.59

Dividends & Yields

Over the twelve months ended June 30, 2026, Biotricity Inc. paid dividends of 0.00 per share. The dividend payout ratio of 21.16 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.91, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.75, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Biotricity Inc. shareholders.

Payout Ratio21.16
Shareholder Yield2.75
FCF Yield4.91

Stock Splits

Biotricity Inc.'s most recent stock split took place on July 3, 2023 with a 6:1 split ratio.

Last Split Date7/3/2023
Split Ratio6:1

Scores

As of June 30, 2026, Biotricity Inc. has an Altman Z-Score of -36.09, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-36.09